Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: HADHA promotes glioma progression by accelerating MDM2-mediated p53 ubiquitination.

Cancer gene therapy·2025
Same author

HADHA promotes glioma progression by accelerating MDM2-mediated p53 ubiquitination.

Cancer gene therapy·2024
Same author

A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis.

Journal of gastroenterology and hepatology·2021
Same author

Overexpression of hsa_circ_0001445 reverses oxLDL‑induced inhibition of HUVEC proliferation via SRSF1.

Molecular medicine reports·2021
Same author

Is there any association between asthma and Kawasaki disease? A systematic review and meta-analysis.

Pediatric pulmonology·2021
Same author

The seborrheic dermatitis-distributed dermatomyositis: A facial cutaneous lesions sign associated with positive anti-MDA5 antibody.

Journal of cosmetic dermatology·2021

Related Experiment Video

Updated: Sep 17, 2025

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
05:51

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

Published on: March 17, 2023

2.0K

Nanoprobe-Based Near-Infrared II Optical Imaging for Guiding Precision Glioma Therapy.

Liang Dong1, Wenzhong Li1, Lulu Li2

  • 1Department of Neurosurgery, Shanxi Provincial People' s Hospital,Shanxi Medical University, Taiyuan, Shanxi, 030012, People' s Republic of China.

International Journal of Nanomedicine
|July 2, 2025
PubMed
Summary

Near-infrared II (NIR-II) fluorescence imaging offers advanced, non-invasive tools for glioma diagnosis and treatment guidance. This review explores NIR-II applications in surgery, drug delivery, and therapy, showing potential for improved patient outcomes.

Keywords:
gliomamultimodal therapynear-infrared IIphototherapysurgery

More Related Videos

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

2.5K
An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy
09:52

An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy

Published on: April 21, 2014

19.9K

Related Experiment Videos

Last Updated: Sep 17, 2025

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
05:51

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

Published on: March 17, 2023

2.0K
Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

2.5K
An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy
09:52

An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy

Published on: April 21, 2014

19.9K

Area of Science:

  • Neuro-oncology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Glioma is an aggressive central nervous system tumor with poor prognosis.
  • Current diagnostic and treatment methods have limitations.
  • Near-infrared II (NIR-II) fluorescence imaging presents a promising non-invasive approach.

Purpose of the Study:

  • To review the applications and advancements of NIR-II fluorescence imaging in glioma diagnosis and treatment.
  • To evaluate the feasibility and practicality of integrating NIR-II technologies into clinical glioma management.
  • To highlight the potential of NIR-II technologies to improve patient prognosis.

Main Methods:

  • Comprehensive literature review of studies utilizing NIR-II fluorescence imaging for glioma.
  • Analysis of NIR-II applications in guiding glioma surgery, targeted drug delivery, and therapy.
  • Evaluation of the technical capabilities of NIR-II imaging, including resolution, sensitivity, and penetration depth.

Main Results:

  • NIR-II fluorescence imaging demonstrates high accuracy and efficiency in real-time glioma treatment guidance.
  • Applications include enhanced visualization during surgery, precise drug delivery, and effective photoacoustic and multimodal therapies.
  • The technology shows feasibility for integration into clinical workflows.

Conclusions:

  • NIR-II fluorescence imaging is a powerful tool with significant potential to improve glioma diagnosis and treatment.
  • Integration of NIR-II technologies can enhance surgical precision and therapeutic efficacy.
  • Further research and clinical studies are needed to address existing challenges and fully realize the clinical benefits.